BioPharma Clinical Trials

Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...

 May 28, 2024 | News

Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome

Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...

 May 28, 2024 | News

Henlius Biotech and Organon Receive EMA Validation for Denosumab Biosimilar HLX14

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing autho...

 May 27, 2024 | News

Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy

Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...

 May 27, 2024 | News

Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA

Telix Pharmaceuticals  announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...

 May 27, 2024 | News

Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment

Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...

 May 24, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

 May 23, 2024 | News

GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'

GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.   With this appr...

 May 21, 2024 | News

Telix Pharmaceuticals' CUPID Study Demonstrates Promising Results for Next-Generation Prostate Cancer Therapy

CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. Establishes ...

 May 21, 2024 | News

Experimental Drug Development Centre (EDDC) Announces Progression of Phase 1 Trial for EBC-129 into Dose Expansion

  EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets cancer cells across ...

 May 20, 2024 | News

Ractigen Therapeutics Receives IND Approval for Phase 1 ALS Clinical Trials in China

Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies,  announces that the Center for Drug ...

 May 16, 2024 | News

EFECON® Becomes First Approved Therapy for IgAN in China, Offering Hope to Millions with Improved Patient Care and Disease Management

Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines ...

 May 15, 2024 | News

Mabwell Advances Clinical Study of Nectin-4-Targeting ADC for Triple-Negative Breast Cancer

Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targ...

 May 14, 2024 | News

Arcellx and Kite Announce Phase 3 Trial for Anito-cel in Multiple Myeloma Patients

  -- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...

 May 10, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close